| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$162,038,028 |
|
|
|
Indirect Value
|
$374,282,250 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$536,320,277 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 46.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-04 |
4 |
B |
$5.17 |
$349,900 |
I/I |
67,679 |
154,803 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-04 |
4 |
B |
$5.17 |
$233,270 |
I/I |
45,120 |
1,078,323 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-06 |
4 |
B |
$5.23 |
$1,364,575 |
I/I |
260,913 |
156,212 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-06 |
4 |
B |
$5.23 |
$909,717 |
I/I |
173,942 |
1,113,111 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-07 |
4 |
B |
$5.26 |
$779,727 |
I/I |
148,237 |
1,142,758 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-07 |
4 |
B |
$5.26 |
$1,169,587 |
I/I |
222,355 |
157,413 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-28 |
4 |
A |
$5.46 |
$999,942 |
I/I |
174,954 |
2,422,517 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-07-31 |
4 |
A |
$7.76 |
$1,000,227 |
I/I |
128,235 |
2,524,944 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-08-30 |
4 |
A |
$6.65 |
$1,000,282 |
I/I |
137,353 |
2,632,209 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-09-30 |
4 |
A |
$5.99 |
$1,000,162 |
I/I |
164,134 |
2,762,970 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-10-31 |
4 |
A |
$5.54 |
$999,513 |
I/I |
170,697 |
2,897,598 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-11-29 |
4 |
A |
$5.35 |
$1,000,123 |
I/I |
185,079 |
3,047,141 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-12-31 |
4 |
A |
$5.66 |
$1,000,640 |
I/I |
175,879 |
3,188,586 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive OfficerOfficer |
• • • |
2013-08-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,375,298 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2003-11-10 |
4 |
A |
$0.00 |
$0 |
I/I |
1,411,600 |
112,890 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2003-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
615,050 |
1,048,191 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2005-11-17 |
4 |
A |
$19.56 |
$6,000,014 |
I/I |
306,710 |
102,236 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2005-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
1,056,191 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-02-09 |
4 |
A |
$23.40 |
$3,588,507 |
I/I |
153,355 |
153,353 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-05-18 |
4 |
B |
$20.00 |
$2,000,000 |
I/I |
100,000 |
366,246 |
2.25 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-06-13 |
4 |
A |
$16.27 |
$5,999,996 |
I/I |
368,720 |
429,912 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-08-22 |
4 |
B |
$12.30 |
$49,348 |
I/I |
4,012 |
512,762 |
2.25 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-08-23 |
4 |
B |
$12.97 |
$162,125 |
I/I |
12,500 |
525,262 |
2.25 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-08-24 |
4 |
B |
$13.17 |
$140,827 |
I/I |
10,693 |
535,955 |
2.25 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-08-25 |
4 |
B |
$13.48 |
$103,756 |
I/I |
7,697 |
543,652 |
2.25 |
- |
|
271 Records found
|
|
Page 7 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
